Form 8-K - Current report:
SEC Accession No. 0001493152-24-008493
Filing Date
2024-03-01
Accepted
2024-03-01 16:15:38
Documents
14
Period of Report
2024-02-28
Items
Item 1.02: Termination of a Material Definitive Agreement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 form8-k.htm   iXBRL 8-K 37897
  Complete submission text file 0001493152-24-008493.txt   209415

Data Files

Seq Description Document Type Size
2 XBRL SCHEMA FILE cocp-20240228.xsd EX-101.SCH 3036
3 XBRL LABEL FILE cocp-20240228_lab.xml EX-101.LAB 34240
4 XBRL PRESENTATION FILE cocp-20240228_pre.xml EX-101.PRE 22373
15 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 3520
Mailing Address 19805 N. CREEK PARKWAY BOTHELL WA 98011
Business Address 19805 N. CREEK PARKWAY BOTHELL WA 98011 (786) 459-1831
Cocrystal Pharma, Inc. (Filer) CIK: 0001412486 (see all company filings)

EIN.: 352528215 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38418 | Film No.: 24709944
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)